I agree this is good value and have a recently jumped on board myself. Considerable tailwinds for this company IMO:
- Ageing populations around the globe (sleep apnea is a function of age)
- Obese populations (sleep apnea is a function of obesity)
- Sleep apnea awareness: is really just starting to wake up (excuse the pun)
- Large overseas revenues: well positioned to benefit from falls in the $A (yes this goes both ways but personally I think $A will head south in coming years).
Reflected in good fundamentals, see picture. DYOR.
Undervalued, page-4
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$38.15 |
Change
0.070(0.18%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $38.10 | $38.22 | $37.91 | $30.20M | 792.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 956 | $38.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $38.15 | 2018 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
